In This Section      
 

Search Results

Title:
Pilot Biomarker Study of Stereotactic Body Radiation Therapy for Prostate Cancer Oligometastases
Protocol Number:
J15203
Phase:
NULL
Physician:
Phuoc Tran
Sites:
Johns Hopkins Kimmel Cancer Center in Baltimore
Purpose:
Will we be able to detect CTCs, ctDNA and/or describe T-cell receptor (TCR) repertoire changes in patients with oligometastatic prostate cancer undergoing SBRT treatment of their metastases.
Eligibility:
Patient must have at least one and up to five asymptomatic or symptomatic metastatic tumor(s) of the bone or soft tissue develop that are equal to 5.0 cm or less than 250 cm³.
Treatment:
Research blood draws on Day 1 of SABR. SABR to 1-5 mets. Then, research blood draws on Day 90 and 180.
Population:
Adult
Last Update
03/05/2019 05:03 AM